[Prophylactic treatment of meningeal leukemia (author's transl)].
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage; D002648:Child; D003561:Cytarabine / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007278:Injections, Spinal; D007938:Leukemia / Q000628:therapy*; D007945:Leukemia, Lymphoid / Q000628:therapy; D008297:Male; D008577:Meningeal Neoplasms / Q000517:prevention & control* / Q000532:radiotherapy / Q000556:secondary; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects; D008875:Middle Aged; D009607:Nitrosourea Compounds / Q000008:administration & dosage; D011832:Radiation Injuries; D011879:Radiotherapy Dosage
D000305:Adrenal Cortex Hormones; D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; D003561:Cytarabine; D008727:Methotrexate
Le traitement prophylactique de la méningite leucémique.